Raymond James & Associates Globus Medical Inc Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Globus Medical Inc stock. As of the latest transaction made, Raymond James & Associates holds 299,294 shares of GMED stock, worth $25.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

299,294

Previous 275,945 8.46%

Holding current value

$25.5 Million

Previous $18.9 Million 13.29%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$67.08 - $73.92 $1.57 Million - $1.73 Million	23,349 Added 8.46%	299,294 $21.4 Million
Q2 2024 Jul 19, 2024	BUY	$49.79 - $68.85 $1.76 Million - $2.44 Million	35,402 Added 14.72%	275,945 $18.9 Million
Q1 2024 Apr 22, 2024	BUY	$51.15 - $56.52 $1.93 Million - $2.13 Million	37,671 Added 18.57%	240,543 $12.9 Million
Q4 2023 Jan 16, 2024	SELL	$43.79 - $55.14 $10.1 Million - $12.7 Million	-229,909 Reduced 53.12%	202,872 $10.8 Million
Q3 2023 Oct 24, 2023	BUY	$49.1 - $62.37 $4.11 Million - $5.22 Million	83,648 Added 23.96%	432,781 $21.5 Million
Q2 2023 Jul 25, 2023	BUY	$52.61 - $59.54 $3.81 Million - $4.31 Million	72,442 Added 26.18%	349,133 $20.8 Million
Q1 2023 Apr 14, 2023	SELL	$51.83 - $79.63 $17.4 Million - $26.7 Million	-335,614 Reduced 54.81%	276,691 $15.7 Million
Q4 2022 Feb 08, 2023	BUY	$58.4 - $75.53 $10.6 Million - $13.7 Million	181,254 Added 42.05%	612,305 $45.5 Million
Q3 2022 Oct 25, 2022	BUY	$55.32 - $67.54 $11.6 Million - $14.2 Million	210,142 Added 95.13%	431,051 $25.7 Million
Q2 2022 Aug 12, 2022	BUY	$53.08 - $81.37 $2.77 Million - $4.25 Million	52,267 Added 30.99%	220,909 $12.4 Million
Q1 2022 May 11, 2022	BUY	$63.68 - $75.54 $195,370 - $231,756	3,068 Added 1.85%	168,642 $12.4 Million
Q4 2021 Feb 08, 2022	BUY	$62.62 - $79.92 $113,029 - $144,255	1,805 Added 1.1%	165,574 $12 Million
Q3 2021 Nov 02, 2021	SELL	$76.41 - $84.06 $232,897 - $256,214	-3,048 Reduced 1.83%	163,769 $12.5 Million
Q2 2021 Aug 11, 2021	SELL	$61.85 - $77.53 $883,279 - $1.11 Million	-14,281 Reduced 7.89%	166,817 $12.9 Million
Q1 2021 May 14, 2021	SELL	$60.05 - $67.74 $2.99 Million - $3.37 Million	-49,709 Reduced 21.54%	181,098 $11.2 Million
Q4 2020 Feb 12, 2021	SELL	$48.89 - $65.87 $1.65 Million - $2.22 Million	-33,760 Reduced 12.76%	230,807 $15.1 Million
Q3 2020 Nov 04, 2020	BUY	$45.26 - $57.82 $2.02 Million - $2.58 Million	44,538 Added 20.24%	264,567 $13.1 Million
Q2 2020 Jul 28, 2020	BUY	$39.81 - $55.61 $1.65 Million - $2.3 Million	41,393 Added 23.17%	220,029 $10.5 Million
Q1 2020 Apr 21, 2020	BUY	$35.06 - $59.45 $3.5 Million - $5.94 Million	99,958 Added 127.05%	178,636 $7.6 Million
Q4 2019 Feb 12, 2020	SELL	$49.45 - $59.5 $303,029 - $364,616	-6,128 Reduced 7.23%	78,678 $4.63 Million
Q3 2019 Nov 07, 2019	BUY	$40.41 - $52.32 $1.53 Million - $1.98 Million	37,816 Added 80.48%	84,806 $4.34 Million
Q2 2019 Aug 06, 2019	BUY	$39.3 - $48.41 $928,619 - $1.14 Million	23,629 Added 101.15%	46,990 $1.99 Million
Q1 2019 May 06, 2019	BUY	$38.08 - $49.41 $338,416 - $439,106	8,887 Added 61.4%	23,361 $1.15 Million
Q4 2018 Feb 11, 2019	BUY	$41.38 - $57.44 $119,464 - $165,829	2,887 Added 24.92%	14,474 $626,000
Q3 2018 Nov 14, 2018	BUY	$50.24 - $56.76 $36,373 - $41,094	724 Added 6.66%	11,587 $658,000
Q2 2018 Aug 14, 2018	BUY	$47.96 - $57.41 $178,890 - $214,139	3,730 Added 52.29%	10,863 $548,000
Q1 2018 May 14, 2018	SELL	$42.75 - $51.73 $564,898 - $683,560	-13,214 Reduced 64.94%	7,133 $355,000
Q4 2017 Feb 14, 2018	SELL	$28.86 - $41.64 $1.24 Million - $1.79 Million	-43,073 Reduced 67.92%	20,347 $836,000
Q3 2017 Nov 13, 2017	BUY	$28.28 - $30.85 $45,021 - $49,113	1,592 Added 2.57%	63,420 $1.89 Million
Q2 2017 Aug 14, 2017	BUY	N/A	61,828	61,828 $2.05 Million

Others Institutions Holding GMED

# of Institutions

480

Shares Held

104M

Call Options Held

183K

Put Options Held

57.3K

View Full List

About GLOBUS MEDICAL INC

Ticker GMED
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 77,037,200
Market Cap $6.57B
Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...

More about GMED

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Globus Medical Inc Transaction History